Valmet Enhances Tissue Production for PT Suparma Tbk

Valmet to Supply Advanced Tissue Machine to PT Suparma Tbk

Valmet Oyj is set to deliver a state-of-the-art IntelliTissue 1600 tissue machine to PT Suparma Tbk in Indonesia. This impressive new installation is intended to enhance the production of high-quality tissue products tailored for the Asia Pacific market, with operations anticipated to commence in the near future.

Strengthening a Successful Partnership

The latest order is part of Valmet's received orders for the second quarter of 2025. While the financial details surrounding the order remain undisclosed, this endeavor further emphasizes the longstanding partnership between Valmet and PT Suparma Tbk, which has a rich history of collaborative projects in the tissue sector. The duo's previous collaboration involved the successful installation of an IntelliTissue machine (TM10) at the same mill, which became operational in a recent year.

Customer Insight

Joseph Sulaiman, Director of PT Suparma Tbk, expressed his enthusiasm: "Expanding our cooperation with Valmet through this new investment in our Tissue Machine is a momentous step. Valmet truly understands our specific needs, and our excellent collaboration during the previous project has established a solid ground for further growth in this partnership. We look forward to what the future holds and our continued cooperation with Valmet."

Valmet’s Commitment to Quality

Pemo Klimczak, Vice President of the SMM business unit at Valmet, shared his confidence in the project: "Our collaboration with PT Suparma Tbk has been longstanding and fruitful. We are proud that they have entrusted us once again with this vital project, which highlights the efficiency of the IntelliTissue concept. It's our aim to accelerate their growth in the tissue market efficiently and effectively together."

Technical Specifications of the Delivery

This delivery will consist of a complete tissue production line, incorporating high-end equipment designed for optimal performance. A key component of this line is the IntelliTissue 1600 machine, which comes equipped with advanced features such as the IntelliJet V headbox, Crescent Former, IntelliPress, and an IntelliYankee dryer, among other essential systems.

Moreover, the new machine encompasses mechanical and electrical drives as well as a Valmet DNA system that includes Machine Control, Distributed Control, and Quality Control System. This comprehensive setup will also have dust removal and additional auxiliary systems necessary for efficient tissue production. Ultimately, this installation is anticipated to add roughly 26,500 tons of annual tissue paper capacity to PT Suparma Tbk's existing base.

About PT Suparma Tbk

Established in 1976, PT Suparma Tbk has grown to become a leading entity in the paper and tissue manufacturing industry in Indonesia. The company prides itself on delivering reliable and high-quality products to both national and international markets. With a strong focus on product innovation, continuous improvements, and environmentally friendly practices, PT Suparma employs recovered fibers in the majority of its offerings, ensuring sustainability while meeting varied customer requirements with its broad product lineup.

Valmet's Global Impact

Valmet stands as a global technology leader dedicated to serving process industries. Its commitment to innovation is apparent in its work with clients throughout the entire lifecycle, supplying cutting-edge technologies, mission-critical automation, and flow control solutions. With over 225 years of industrial experience and a global workforce of over 19,000 professionals, Valmet is well-equipped to drive transformative changes across industries, propelling them towards a sustainable future.

In a recent fiscal year, Valmet reported net sales of approximately EUR 5.4 billion, with its headquarters situated in Espoo, Finland. The company operates internationally, leveraging expertise from around 40 countries, with shares listed on Nasdaq Helsinki.

Frequently Asked Questions

What is the purpose of Valmet's delivery to PT Suparma Tbk?

Valmet is delivering an IntelliTissue 1600 tissue machine to enhance PT Suparma Tbk's production of high-quality tissue products for the Asia Pacific market.

What are the key features of the new tissue machine?

The new machine features an IntelliJet V headbox, Crescent Former, IntelliPress, and an IntelliYankee dryer along with mechanical drives and a Valmet DNA system.

How has the partnership between Valmet and PT Suparma developed over the years?

Valmet and PT Suparma have a strong partnership history, having successfully collaborated on several projects, including the recent installation of another tissue machine.

What impact will the new tissue machine have on production capacity?

The installation is projected to increase PT Suparma Tbk's tissue paper production capacity by 26,500 tons annually.

What is Valmet's role in the technology sector?

Valmet is a global technology leader that offers advanced technologies and services for process industries, focusing on innovation and sustainability.

About The Author

Hey there I'm Caleb Price, a writer and financial specialist who loves to assist others in understanding the financial world. Having years of practical experience and a solid background in finance, my area of expertise is converting difficult financial ideas into useful, doable insights for my blog and publications. My goal with my writing is to give readers the information and assurance they need to successfully negotiate their financial journeys.

My ability to interact with a wide range of people—from novices starting their investing journey to seasoned investors looking for new approaches—has come from contributing to several financial blogs. Making money approachable and understandable is my goal; this will enable you to make wise choices and realize your financial objectives. We appreciate you coming along on this path to success and financial empowerment on Investors Hangout.

Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.